Bluejay Diagnostics, Inc. (BJDX)
Automate Your Wheel Strategy on BJDX
With Tiblio's Option Bot, you can configure your own wheel strategy including BJDX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BJDX
- Rev/Share 0.549
- Book/Share 9.3813
- PB 0.3603
- Debt/Equity 0.0387
- CurrentRatio 2.9183
- ROIC -1.816
- MktCap 1532942.0
- FreeCF/Share -16.1026
- PFCF -0.2418
- PE -0.1942
- Debt/Assets 0.0292
- DivYield 0
- ROE -1.4749
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Published: October 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
ACTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 2,250,000 shares of common stock (or pre-funded warrant in lieu thereof) and Series F warrants to purchase up to 4,500,000 shares of common stock at a purchase price of $2.00 per share of common stock (or per pre-funded warrant in lieu thereof) and accompanying warrants in a private placement priced at-the-market under Nasdaq rules. The …
Read More
About Bluejay Diagnostics, Inc. (BJDX)
- IPO Date 2021-11-10
- Website https://bluejaydx.com
- Industry Medical - Devices
- CEO Indranil Dey
- Employees 7